Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Ahlgren

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Bioconjugate Chemistry|October 23, 2010
HEHEHE-tagged affibody molecule may be purified by IMAC, is conveniently labeled with [⁹⁹(m)Tc(CO)₃](+), and shows improved biodistribution with reduced hepatic radioactivity accumulationVladimir Tolmachev, Camilla Hofström, Jennie Malmberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 9, 2009
Design, synthesis and biological evaluation of a multifunctional HER2-specific Affibody molecule for molecular imagingThuy A Tran, Daniel Rosik, Lars Abrahmsén, et al.
Bioconjugate Chemistry|January 1, 2008
Evaluation of maleimide derivative of DOTA for site-specific labeling of recombinant affibody moleculesSara Ahlgren, Anna Orlova, Daniel Rosik, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2010
Targeting of HER2-expressing tumors using 111In-ABY-025, a second-generation affibody molecule with a fundamentally reengineered scaffoldSara Ahlgren, Anna Orlova, Helena Wållberg, et al.
Bioconjugate Chemistry|July 16, 2008
Evaluation of a maleimido derivative of CHX-A'' DTPA for site-specific labeling of affibody moleculesVladimir Tolmachev, Heng Xu, Helena Wållberg, et al.
Molecular Biology of the Cell|December 21, 2010
Role of Pax3 acetylation in the regulation of Hes1 and Neurog2Shunsuke Ichi, Vanda Boshnjaku, Yueh-Wei Shen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2009
Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteineSara Ahlgren, Helena Wållberg, Thuy A Tran, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Bioconjugate Chemistry|October 23, 2010
HEHEHE-tagged affibody molecule may be purified by IMAC, is conveniently labeled with [⁹⁹(m)Tc(CO)₃](+), and shows improved biodistribution with reduced hepatic radioactivity accumulationVladimir Tolmachev, Camilla Hofström, Jennie Malmberg, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 9, 2009
Design, synthesis and biological evaluation of a multifunctional HER2-specific Affibody molecule for molecular imagingThuy A Tran, Daniel Rosik, Lars Abrahmsén, et al.
Bioconjugate Chemistry|January 1, 2008
Evaluation of maleimide derivative of DOTA for site-specific labeling of recombinant affibody moleculesSara Ahlgren, Anna Orlova, Daniel Rosik, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2010
Targeting of HER2-expressing tumors using 111In-ABY-025, a second-generation affibody molecule with a fundamentally reengineered scaffoldSara Ahlgren, Anna Orlova, Helena Wållberg, et al.
Bioconjugate Chemistry|July 16, 2008
Evaluation of a maleimido derivative of CHX-A'' DTPA for site-specific labeling of affibody moleculesVladimir Tolmachev, Heng Xu, Helena Wållberg, et al.
Molecular Biology of the Cell|December 21, 2010
Role of Pax3 acetylation in the regulation of Hes1 and Neurog2Shunsuke Ichi, Vanda Boshnjaku, Yueh-Wei Shen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2009
Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteineSara Ahlgren, Helena Wållberg, Thuy A Tran, et al.
Pageof 2